Drug
Ptc844
Ptc844: highest development phase Phase 2, developed by PTC Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- PTC Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| PTC844 NCT07779616 | Phase 2 | Rheumatoid Arthritis |
Latest
No recent events.
Follow Ptc844 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.